Bon Natural Life (BON) Common Equity (2020 - 2025)

Bon Natural Life (BON) has disclosed Common Equity for 6 consecutive years, with $57.6 million as the latest value for Q3 2025.

  • Quarterly Common Equity rose 31.07% to $57.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $57.6 million through Sep 2025, up 31.07% year-over-year, with the annual reading at $57.6 million for FY2025, 31.07% up from the prior year.
  • Common Equity for Q3 2025 was $57.6 million at Bon Natural Life, up from $43.9 million in the prior quarter.
  • The five-year high for Common Equity was $57.6 million in Q3 2025, with the low at $26.5 million in Q3 2021.
  • Average Common Equity over 5 years is $38.8 million, with a median of $36.0 million recorded in 2023.
  • The sharpest move saw Common Equity skyrocketed 140.72% in 2021, then rose 13.41% in 2022.
  • Over 5 years, Common Equity stood at $26.5 million in 2021, then increased by 13.41% to $30.1 million in 2022, then increased by 19.57% to $36.0 million in 2023, then grew by 22.02% to $43.9 million in 2024, then skyrocketed by 31.07% to $57.6 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $57.6 million, $43.9 million, and $36.0 million for Q3 2025, Q3 2024, and Q3 2023 respectively.